Delivery Order SPE2DH25D0001-SPE2D426F7685

<p>The Defense Logistics Agency Medical Supply Chain issued a delivery order to Abbott Laboratories Inc. on February 10, 2026, with a ceiling value of $1,466 for CHEM 8 cartridge supply. Place of performance is North Chicago, Illinois. The order carries fixed-price pricing with economic price adjustment and an ultimate completion date of February 12, 2026. No set-aside was used.</p>

<p>The Defense Logistics Agency Medical Supply Chain issued a $1,466 delivery order to Abbott Laboratories Inc. on February 10, 2026, for CHEM 8 cartridges.</p> <p>Place of performance is North Chicago, IL. The order carries a fixed-price structure with economic price adjustment and an ultimate completion date of February 12, 2026. No set-aside was used.</p>

<p>The Defense Logistics Agency Medical Supply Chain issued a delivery order to Abbott Laboratories Inc. on February 6, 2026, with a ceiling value of $3,819.75 for CG8+ cartridge supply.</p> <p>Place of performance is North Chicago, Illinois. The order is fixed price with economic price adjustment. Ultimate completion date is February 10, 2026. No set-aside was used.</p>

<p>The Defense Logistics Agency Medical Supply Chain issued a delivery order to Abbott Laboratories Inc. on February 10, 2026, with a ceiling value of $1,612.00 for CARTRIDGE CG4+ TE 25S under a fixed-price contract with economic price adjustment.</p> <p>Place of performance is North Chicago, IL 60064. Ultimate completion date is February 12, 2026. No set-aside was used for this order.</p>

<p>The Defense Logistics Agency Medical Supply Chain issued a delivery order to Abbott Laboratories Inc. on February 6, 2026, with a ceiling value of $6,565.50 for CG8+ cartridge supply.</p> <p>Place of performance is North Chicago, IL. The order is priced on a fixed-price basis with economic price adjustment and has an ultimate completion date of February 10, 2026. No set-aside was used.</p>

<p>The Defense Logistics Agency Medical Supply Chain issued a $2,806.75 delivery order to Abbott Laboratories Inc. on February 9, 2026, for CG8+ cartridge supply. Place of performance is North Chicago, IL. The order carries a fixed-price structure with economic price adjustment and an ultimate completion date of February 11, 2026. No set-aside was used.</p>

Abbott Laboratories Inc. received a $2,064.52 fixed-price delivery order from the Defense Logistics Agency Medical Supply Chain on January 7, 2026, with an ultimate completion date of January 9, 2026. The contract covers CG8+ cartridge supplies and will be performed in North Chicago, Illinois. This delivery order was awarded without a set-aside designation under full and open competition, reflecting Abbott's established competitive position as a critical federal supplier of diagnostic and...

Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $1,165.88 on January 27, 2026, by the Defense Logistics Agency Medical Supply Chain for the provision of Chemistry 8 cartridges. The contract utilizes a fixed-price structure with economic price adjustment provisions and is scheduled for ultimate completion by January 29, 2026. The award was made without a set-aside designation, reflecting full and open competition in the federal...

The U.S. Defense Medical Supply Chain awarded a $2,199.00 fixed-price delivery order with economic price adjustment to Abbott Laboratories Inc. (Abbott Point of Care division) on August 25, 2025, for the supply of Chemistry 8 cartridges. The contract, which reaches ultimate completion on August 27, 2025, was awarded without set-aside designation, indicating full and open competition. Performance will occur at Abbott's North Chicago, Illinois facility, where the company manufactures point-of-care...

Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $2,512.96 on December 18, 2025, for Chemistry 8 cartridges under a Defense Logistics Agency Medical Supply Chain contract. The order, with an ultimate completion date of December 22, 2025, utilizes a fixed-price contract type with economic price adjustment provisions and carries no small business set-aside designation. Performance will be executed at Abbott's facility in North Chicago,...